Delaware
|
001-37568
|
26-4231384
|
(State or other jurisdiction of incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
300 Connell Drive, Suite 4000
Berkeley Heights, NJ
|
07922
|
|
(Address of principal executive offices)
|
(Zip Code)
|
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 5.07 |
Submission of Matters to a Vote of Security Holders.
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|||
15,588,684
|
1,999,879
|
309,481
|
10,183,441
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|||
25,611,216
|
1,887,467
|
582,802
|
0
|
For
|
Against
|
Abstain
|
Broker Non-Votes
|
|||
12,869,177
|
2,897,231
|
2,131,636
|
10,183,441
|
Edge Therapeutics, Inc.
|
||
Date: March 14, 2019
|
/s/ Andrew Saik
|
|
Name:
|
Andrew Saik
|
|
Title:
|
Chief Financial Officer
|